There has been a decrease in new HIV infections and deaths worldwide, showing progress in the fight against the disease. However, health experts caution that HIV is still a significant global health concern as World AIDS Day approaches on Sunday.
Progress Variation
A study published in The Lancet HIV journal revealed that during the 2010s, global HIV infections dropped by 20%. Additionally, deaths related to HIV decreased by approximately 40% to below one million annually, with significant improvements seen in sub-Saharan Africa.
Despite these advancements, regions like Eastern Europe and the Middle East experienced an increase in HIV cases. The world is still far from achieving the UN goal of eliminating AIDS-related deaths by 2030.
Lead study author Hmwe Kyu from the Institute For Health Metrics and Evaluation stated, “The world has made remarkable progress in reducing new HIV infections, but over a million people still acquire HIV each year, and a quarter of the 40 million people living with HIV are not receiving treatment.”
– Effective Strategies –
Preventative measures like Pre-Exposure Prophylaxis (PrEP) have shown to be effective in reducing HIV transmission. These daily pills can lower the risk of HIV contraction from sex by 99%, contributing to decreased HIV rates in many countries.
Antiretroviral therapy for those living with HIV can reduce viral levels to undetectable, minimizing the risk of transmission, especially from mother to child during breastfeeding.
Potential Breakthrough
Research on lenacapavir, an antiretroviral drug, has shown promising results in preventing HIV infection with just two injections yearly. Despite the high cost, efforts are being made to ensure accessibility in low-income nations.
Gilead, the pharmaceutical company producing lenacapavir, has partnered with generic drugmakers to distribute the drug at more affordable prices in developing countries.
Hope for a Vaccine
Although a vaccine for HIV remains elusive, lenacapavir’s efficacy in preventing infection is likened to a vaccine. While a cure for HIV is rare and complex, advancements like lenacapavir offer hope in the battle against the disease.
(Except for the headline, this article has been paraphrased from a syndicated feed without any modifications by NDTV staff.)
